ONMD vs. LUNA, NOTV, BIAF, AIKI, DKDCA, ISPC, FOXO, IQV, ICLR, and INCY
Should you be buying OneMedNet stock or one of its competitors? The main competitors of OneMedNet include Luna Innovations (LUNA), Inotiv (NOTV), bioAffinity Technologies (BIAF), AIkido Pharma (AIKI), Data Knights Acquisition (DKDCA), iSpecimen (ISPC), FOXO Technologies (FOXO), IQVIA (IQV), ICON Public (ICLR), and Incyte (INCY). These companies are all part of the "commercial physical research" industry.
Luna Innovations (NASDAQ:LUNA) and OneMedNet (NASDAQ:ONMD) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, community ranking, risk and institutional ownership.
Luna Innovations currently has a consensus price target of $10.00, indicating a potential upside of 199.40%. Given OneMedNet's higher possible upside, equities analysts clearly believe Luna Innovations is more favorable than OneMedNet.
Luna Innovations received 199 more outperform votes than OneMedNet when rated by MarketBeat users.
Luna Innovations has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, OneMedNet has a beta of -0.46, suggesting that its share price is 146% less volatile than the S&P 500.
Luna Innovations has higher revenue and earnings than OneMedNet. Luna Innovations is trading at a lower price-to-earnings ratio than OneMedNet, indicating that it is currently the more affordable of the two stocks.
87.5% of Luna Innovations shares are owned by institutional investors. Comparatively, 1.0% of OneMedNet shares are owned by institutional investors. 7.6% of Luna Innovations shares are owned by company insiders. Comparatively, 45.7% of OneMedNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Luna Innovations had 14 more articles in the media than OneMedNet. MarketBeat recorded 18 mentions for Luna Innovations and 4 mentions for OneMedNet. Luna Innovations' average media sentiment score of 1.29 beat OneMedNet's score of 0.31 indicating that OneMedNet is being referred to more favorably in the news media.
OneMedNet has a net margin of 0.00% compared to OneMedNet's net margin of -1.82%. OneMedNet's return on equity of 3.61% beat Luna Innovations' return on equity.
Summary
Luna Innovations beats OneMedNet on 11 of the 16 factors compared between the two stocks.
Get OneMedNet News Delivered to You Automatically
Sign up to receive the latest news and ratings for ONMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ONMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OneMedNet Competitors List
Related Companies and Tools
